leisure time -WSS

leisure time

author：entertainment 2025-09-27 06:09:38 - browse：67382

1:56Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Target has recalled another 2.2 million of its Threshold candles due to reports of candle jars breaking or cracking during use.

In May, the United States Consumer Product Safety Commission announced the recall of nearly 5 million Target Threshold candle products after the retailer received 137 reports of it breaking or cracking during use.

Now, the Minnesota-based retailer has recalled another 2.2 million candles, the CPC announced Thursday.

"Target received 19 reports of the candle jar breaking or cracking during use, resulting in one minor injury," the agency stated.

MORE: General Motors recalls over 600K cars due to car seat safety issue

Six injuries were reported in the previous recall, including lacerations and severe burns, according to the CPSC.

"This recall involves certain Threshold Glass Jar 5.5 ounce 1-Wick, 14 ounce 3-Wick and 20 ounce 3-Wick Candles in multiple scents," the CPSC stated. "The recalled item numbers are printed on the bottom of the glass jars."

PHOTO: Threshold Glass Jar Candles sold exclusively by Target. — Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Click here for a full list of the recalled product details and item numbers.

The CPSC urged consumers to stop using the recalled candles immediately and return them to Target for a refund. Customers can also contact Target for a prepaid return label to send them back by mail.

The candles, which were manufactured in Vietnam, were sold at Target stores nationwide as well as online from August 2019 through March 2023 for between $3 and $20.

An earlier version of this story was originally published May 19, 2023.

Previous article： Hollywood unions extend contract negotiations for actors
Next article： STAT Summit: Ending the crisis of Black deaths in the U.S.

leisure time

WSS

Transgender women dream of pregnancy via uterus transplants

UnitedHealth, Optum discontinue NaviHealth name

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Roivant's CEO is a star, but biotech's black hole persists

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

hotspot

leisure time

MORE: General Motors recalls over 600K cars due to car seat safety issue

leisure time

Hepatitis C has a cure — but many Americans still lack access to it

Novartis develops a rapidly manufactured CAR

Activists slam private health insurers over coverage restrictions

New requirements coming in 2024 for Americans traveling to Europe

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Roche drug slashes death risk in early

The cancer drug shortage isn’t new — and neither are the solutions

Study on Amgen’s bispecific immunotherapy produces positive data

As demand for Covid shots wanes, Moderna seeks its next success

Burning questions about Delta and the next phase of the Covid pandemic

Wikipedia

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Where does female orgasm come from? Scientists think they know

Study on Amgen’s bispecific immunotherapy produces positive data

leisure time

hotspot

leisure time

entertainment